These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 164475

  • 1. Requirement of bromodeoxyuridine for the maintenance of "transformed" characteristics in bromodeoxyuridine dependent cells.
    Horn D, Davidson RL.
    J Cell Physiol; 1975 Apr; 85(2 Pt 1):251-60. PubMed ID: 164475
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Establishment and preliminary growth characteristics of a transformed mouse cerebral microvessel endothelial cell line.
    Robinson RA, TenEyck CJ, Hart MN.
    Lab Invest; 1986 May; 54(5):579-88. PubMed ID: 2871227
    [Abstract] [Full Text] [Related]

  • 8. Enhanced expression of HLA-DR antigens by the human melanoma cell line CaCL 73-36 upon induction of a less differentiated phenotype with bromodeoxyuridine.
    Kawakubo Y, Liao SK.
    Anticancer Res; 1986 May; 6(5):1197-204. PubMed ID: 3800326
    [Abstract] [Full Text] [Related]

  • 9. Bromodeoxyuridine in tumors and chromosomes detected with a monoclonal antibody.
    Morstyn G, Hsu SM, Kinsella T, Gratzner H, Russo A, Mitchell JB.
    J Clin Invest; 1983 Nov; 72(5):1844-50. PubMed ID: 6355188
    [Abstract] [Full Text] [Related]

  • 10. [A review of cell kinetic studies on brain tumors with special reference to anti-bromodeoxyuridine monoclonal antibody method].
    Nagashima T, Hoshino T.
    No Shinkei Geka; 1984 Aug; 12(9):1007-18. PubMed ID: 6390240
    [Abstract] [Full Text] [Related]

  • 11. Requirement of long progression time for the expression of neoplastic phenotypes following direct perturbation to specific region(s) of DNA of Syrian hamster embryo cells.
    Tsutsui T, Ts'o PO.
    Cancer Res; 1986 Jul; 46(7):3533-7. PubMed ID: 3708584
    [Abstract] [Full Text] [Related]

  • 12. Patching, microvilli, and the agglutination of normal and transformed cells.
    Ukena TE, Karnovsky MJ.
    Prog Clin Biol Res; 1976 Jul; 9():261-73. PubMed ID: 1030804
    [Abstract] [Full Text] [Related]

  • 13. Lack of correlation between growth characteristics, agglutinability by plant lectins and the malignant phenotype.
    Berman LD.
    Int J Cancer; 1975 Jun 15; 15(6):973-9. PubMed ID: 1150351
    [Abstract] [Full Text] [Related]

  • 14. The cellular effect of 5-bromodeoxyuridine on the mammalian embryo.
    Bannigan J, Langman J.
    J Embryol Exp Morphol; 1979 Apr 15; 50():123-35. PubMed ID: 458350
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Purification and biological properties of type beta transforming growth factor from mouse transformed cells.
    Fernandez-Pol JA, Klos DJ, Grant GA.
    Cancer Res; 1986 Oct 15; 46(10):5153-61. PubMed ID: 3489522
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.